| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/10/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/10/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/10/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/02/24 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 04/30/24 | 8-K | Current report filing |
|
   |
29 |
| 04/25/24 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 04/24/24 | 8-K | Current report filing |
|
|
3 |
| 04/09/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
82 |
| 03/21/24 | 8-K | Current report filing |
|
|
3 |
| 03/20/24 | EFFECT | Notice of Effectiveness |
|
1 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.